Elizabeth Fabre
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.
Journal: Translational lung cancer research
Published: March 27, 2026
Efficacy and safety of second-line treatments in patients with advanced EGFR-mutated non-small cell lung cancer progressing on osimertinib without identified targetable resistance mechanism at progression.
Journal: Respiratory medicine and research
Published: October 12, 2025
Immune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor Nephritis.
Journal: Kidney international reports
Published: June 26, 2025
Fake It till You Predict It: Data Augmentation Strategies to Detect Initiation and Termination of Oncology Treatment.
Journal: Studies in health technology and informatics
Published: May 17, 2025
Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: September 20, 2024
Resting energy expenditure as a predictor of immune checkpoint inhibitors response in older patients with non-small cell metastatic lung cancer: A pooled analysis of two prospective cohort studies.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: September 02, 2024
Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 06, 2024
Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer.
Journal: Exploration of targeted anti-tumor therapy
Published: August 05, 2024
MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience.
Journal: Scientific reports
Published: June 03, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.
Journal: Translational lung cancer research
Published: April 11, 2024
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: March 04, 2024
Last Updated: 09/26/2026